Mar 12, 2019 / 02:15PM GMT
Jack Meehan - Barclays Bank PLC, Research Division - VP & Senior Research Analyst
Okay. Well, thank you. Good morning. Our third presentation in the morning with Quest CFO, Mark Guinan; as well as Head of Investor Relations, Shawn Bevec, here from Quest and I'm Jack Meehan, the Life Science Tools and Diagnostics analyst.
We're going to start with some audience response questions. So we'll kick those off. Please use the BlackBerry device in front of you.
Questions and Answers:
Jack Meehan - Barclays Bank PLC, Research Division - VP & Senior Research AnalystQuestion #1. What do you view as Quest's organic growth profile over the next 3 years? We're testing who went to the Analyst Day.
Mark J. Guinan - Quest Diagnostics Incorporated - Executive VP & CFO
As we provided at the Analyst Day in November, we gave a 4-year outlook, as you recall, Jack, and talked about 3% to 5% overall growth with about 200 basis points coming from M&A. So that would imply a low single digit.
Trustpilot
